RG
Redmile Group’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42M | Hold |
15,666,731
| – | – | 4.47% | 9 |
|
|
2025
Q1 | $22.1M | Hold |
15,666,731
| – | – | 2.09% | 14 |
|
|
2024
Q4 | $31.2M | Sell |
15,666,731
-2,486
| -0% | -$4.95K | 2.17% | 17 |
|
|
2024
Q3 | $49.4M | Buy |
15,669,217
+400,000
| +3% | +$1.26M | 2.91% | 12 |
|
|
2024
Q2 | $48.3M | Hold |
15,269,217
| – | – | 2.92% | 9 |
|
|
2024
Q1 | $68.6M | Sell |
15,269,217
-59,100
| -0.4% | -$265K | 2.52% | 9 |
|
|
2023
Q4 | $25.4M | Buy |
15,328,317
+1,150,272
| +8% | +$1.91M | 0.91% | 32 |
|
|
2023
Q3 | $12.7M | Buy |
14,178,045
+128,110
| +0.9% | +$115K | 0.61% | 38 |
|
|
2023
Q2 | $30.2M | Buy |
14,049,935
+484,686
| +4% | +$1.04M | 1.16% | 27 |
|
|
2023
Q1 | $26.5M | Buy |
13,565,249
+5,974,400
| +79% | +$11.7M | 1.15% | 32 |
|
|
2022
Q4 | $29.1M | Buy |
7,590,849
+78,820
| +1% | +$303K | 1.19% | 27 |
|
|
2022
Q3 | $36.2M | Hold |
7,512,029
| – | – | 1.4% | 22 |
|
|
2022
Q2 | $59.7M | Buy |
7,512,029
+79,600
| +1% | +$633K | 2.28% | 12 |
|
|
2022
Q1 | $109M | Sell |
7,432,429
-18,600
| -0.2% | -$273K | 3.41% | 7 |
|
|
2021
Q4 | $151M | Sell |
7,451,029
-78,300
| -1% | -$1.58M | 3.42% | 7 |
|
|
2021
Q3 | $204M | Buy |
7,529,329
+7,300
| +0.1% | +$198K | 3.57% | 5 |
|
|
2021
Q2 | $183M | Buy |
7,522,029
+213,611
| +3% | +$5.2M | 2.71% | 7 |
|
|
2021
Q1 | $178M | Buy |
7,308,418
+549,624
| +8% | +$13.4M | 2.51% | 9 |
|
|
2020
Q4 | $216M | Buy |
6,758,794
+405,700
| +6% | +$13M | 2.62% | 10 |
|
|
2020
Q3 | $210M | Buy |
6,353,094
+827,224
| +15% | +$27.3M | 3.85% | 7 |
|
|
2020
Q2 | $259M | Buy |
+5,525,870
| New | +$259M | 4.78% | 4 |
|